Heparin-Induced Thrombocytopenia Test 3/3 Flashcards
In the Coagulation Cascade A portion of protein is cleaved off to form an active enzyme ?
(a serine protease)
Heparin binds to a lysine site on AT, inducing a conformational change at the ?
This converts AT from a slow, progressive clotting factor inhibitor to ?
clotting factor binding site
a very rapid inhibitor of thrombin and factor Xa
What molecules are most responsive to inhibition by the the binding of ATIII to heparin ?
Thrombin X10 fold and factor Xa
Other heparin mechanisms of action include binding directly to
platelets and binding cofactor II
Multiple causes of Heparin Resistance
- AT deficiency,
- Increased heparin clearance,
- Elevations in heparin binding proteins, such as:
- factor VIII,
- fibrinogen, and
- platelet factor 4 (PF4)
There are some Reports of heparin resistance induced by ?
aprotinin and nitroglycerin
Heparin Clearance involves a combination of:
- ) Rapid, saturable phase through binding to receptors on endothelial cells and macrophages that leads to metabolism in the
- ) Slower first-order __ ___
- ) reticuloendothelial system - (main mechanism of clearance of therapeutic doses.
- ) renal elimination
Heparin Dose vs. Half Life ?
25 U/kg
100 U/kg
400 U/kg
30 min
60 min
150 min
4 Protamine – Adverse Reactions ?
Hypotension
Anaphylactic
Anaphylactoid
Pulmonary vasoconstriction
Protamine Adverse Reaction of Pulmonary vasoconstriction can lead to what ?
- Rt ventricular failure,
- decreased CO,
- systemic hypotension
Ag/Ab complexes interact with platelets and endothelial cells, resulting in release of ?
- platelet microparticles,
- thromboxane, and
- massive thrombin generation
Thrombosis typically characterized by presence of white clots rich in platelets, AKA ?
(white clot syndrome)
HIT should be suspected in any patient who develops what ?
50% reduction of platelet count while on heparin treatment
Laboratory that detects binding of antibody to heparin/PF 4 complexes /
ELISA
Functional Assays –
similar sensitivity to ELISA with improved ?
specificity
Should be avoided during acute HIT
Warfarin
Depletion of protein C anticoagulant can lead to limb necrosis resulting from microvascular thrombosis – usually seen when INR rises above
3.5
Thrombin inhibitors
Argatroban
Lepirudin
Bivalirudin
- Synthetic L-arginine derivative
- Exerts its anticoagulant effects by competitively and reversibly inhibiting thrombin
- Binds directly to the catalytic site of thrombin, independently of AT III.
Argatroban
Monitor with PTT & PT
- a 65-amino acid polypeptide secreted by the salivary glands of the medicinal leech.
- Most potent natural thrombin inhibitor known
- Binds to and inhibits both soluble and clot-bound thrombin.
- No antidote is available
Lepirudin
monitored with PTT (goal 2.5x normal)
High risk of bleeding with supratherapeutic levels of Lepirudin.
In cases of severe bleeding what can we do ?
- modified ultrafiltration,
- hemofiltration, and
- hemodialysis have been used to reduce lepirudin concentrations
- A synthetic 20-amino acid peptide of two short hirudin peptide fragments connected by a tetraglycine spacer
- Neutralizes the fibrinogen binding site and catalytic site of thrombin
- Lower rate of hemorrhage than lepirudin
- Reversible thrombin inhibitor
Bivalirudin
HIT antibodies are transient – usually decline to nondetectable levels by
100 days (median 50 days)
If urgent surgery and > 100 days since heparin exposure, it is considered ?
safe to proceed with heparin
After surgery, nonheparin anticoagulants should be used if antithrombotic prophylaxis is needed you should use the following?
Warfarin,
danaparoid 750 U SQ bid-tid, lepirudin 15 mg SQ bid
Eliminated primarily by hepatic mechanisms, and may be useful for patients with renal failure describes what drug ?
Argatroban
A snake venom prothrombin activator-based assay
Ecarin Clotting Time (ECT)
Target CPB lepirudin levels are between ?
3.5-4.0 mcg/mL
Lepirudin Levels >4.0 are associated with ?
increased post-op bleeding
Lepirudin Levels
clotting in the CPB circuit
What percentage of lepirudin distributes in the extravascular space?
80%